Last reviewed · How we verify
Herpes zoster keratoconjunctivitis
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Herpes zoster keratoconjunctivitis patent landscape — cliff calendar, originator estates, attackable patents
- Herpes zoster keratoconjunctivitis treatment landscape brief
- Herpes zoster keratoconjunctivitis treatment updates RSS
Frequently asked questions about Herpes zoster keratoconjunctivitis
What drugs treat Herpes zoster keratoconjunctivitis?
Tracked treatments include Lotemax.
What is the treatment for Herpes zoster keratoconjunctivitis?
Standard treatment for Herpes zoster keratoconjunctivitis includes Lotemax. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Herpes zoster keratoconjunctivitis patent cliff · Herpes zoster keratoconjunctivitis CI report
- Treatment: Lotemax · Bausch Health
- Treatment: Lotemax · Tufts Medical Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing